The tumor-stroma interface provided another demonstration of probe specificity: for example, in a KRAS G12D homozygous mutant tumor, positive signal from the KRAS wild-type probe was only evident in stromal cells (Supplementary Fig. 2b). This evidence concerns the gene KRAS and neoplasm.